Item 7.01 Regulation FD Disclosure.



On November 12, 2021, Immunovant, Inc. issued a press release that it will
provide a presentation regarding its business at the Stifel 2021 Virtual
Healthcare Conference on November 17, 2021. Copies of the press release and the
presentation are attached hereto as Exhibits 99.1 and 99.2, respectively, and
are incorporated herein by reference.

The information furnished under this Item 7.01, including Exhibits 99.1 and
99.2, shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or subject to the liabilities of that section.
The information shall not be deemed incorporated by reference into any other
filing with the SEC made by Immunovant, regardless of any general incorporation
language in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits
Exhibit No.                  Description
99.1                           Press Release, dated November 12, 2021.
99.2                           Presentation, dated November 17, 2021.
104                          Cover Page Interactive Data File (embedded

within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses